Berwyn, PA, United States of America

Michael Rycyzyn

USPTO Granted Patents = 18 


 

Average Co-Inventor Count = 6.9

ph-index = 5

Forward Citations = 154(Granted Patents)


Location History:

  • Spring House, PA (US) (2015 - 2017)
  • Berwyn, PA (US) (2009 - 2023)

Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Michael Rycyzyn: Innovator in Antibody Research

Introduction: Michael Rycyzyn, based in Berwyn, PA, is a prominent inventor with an impressive portfolio of 18 patents. His work primarily revolves around the development of innovative antibody therapies that have significant implications in the medical field.

Latest Patents: Among his latest innovations are patents for Anti-IL-23 antibodies, which include isolated nucleic acids that encode these antibodies, various vectors, host cells, and transgenic organisms. These developments are intended for applications in diagnostics and therapies related to IL-23. Additionally, he has patented Neutralizing human anti-CD27 antibodies, which are designed to block CD27's interaction with its ligand CD70. This patent addresses multiple aspects of CD27's bioactivity, impacting T-cell and B-cell functions and offering potential in diagnosing and treating diseases associated with CD27 activities.

Career Highlights: Michael has had an esteemed career, contributing to significant advancements in biotechnology during his tenure at Janssen Biotech, Inc. and Centocor, Inc. His work in these companies has fostered the development of breakthrough treatments that leverage his deep understanding of immunology and antibody engineering.

Collaborations: Throughout his career, Michael has collaborated with talented individuals such as Jill M Giles-Komar and Raymond W Sweet. These partnerships have played a crucial role in advancing his research and leading to impactful innovations in the field of antibody therapies.

Conclusion: Michael Rycyzyn stands out as an innovative force in biomedical research, particularly in antibody development. His 18 patents reflect a dedication to addressing complex medical challenges through science, and his contributions will likely continue to resonate in the healthcare sector for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…